Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study
Splenomegaly is one of the major clinical manifestations of primary myelofibrosis and is common also in other chronic Philadelphia-negative myeloproliferative neoplasms, causing symptoms and signs and affecting quality of life of patients diagnosed with these diseases. We aimed to study the impact t...
Main Authors: | Vincenzo Accurso, Marco Santoro, Simona Raso, Angelo Davide Contrino, Paolo Casimiro, Florinda Di Piazza, Alessandro Perez, Antonio Russo, Sergio Siragusa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-12-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | https://pagepress.org/journals/index.php/hr/article/view/8281 |
Similar Items
-
Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia
by: Julien M. P. Grenier, et al.
Published: (2024-01-01) -
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
by: Federico Lussana, et al.
Published: (2017-02-01) -
Clinical features of children with polycythemia vera, essential thrombocythemia, and primary myelofibrosis in Japan: A retrospective nationwide survey
by: Hisashi Ishida, et al.
Published: (2020-07-01) -
Prevalence and clinical outcomes of polycythemia vera and essential thrombocythemia with hydroxyurea resistance or intolerance
by: Kittitat Chiaranairungrot, et al.
Published: (2022-12-01) -
Essential thrombocythemia: Rare cause of chorea
by: Eswaradass Prasanna Venkatesan, et al.
Published: (2014-01-01)